PT-141 is a cutting-edge cyclic melanocortin agonist that possesses potential in the treatment of sexual dysfunction. This novel compound operates by enhancing specific receptors across the body, causing to improved sexual performance. Clinical studies have indicated that PT-141 has the potential to effectively manage a spectrum of sexual dysfunct